Collaborative studies explore alternatives to cancer diagnosis

Papers from the Manipal College of Pharmaceutical Sciences and the University of Kentucky explore new options for diagnosing lung cancer.

Dr. Mahadev Rao, Professor and Head of the Department of Pharmacy Practice at the Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE) and his team, in collaboration with a team from the University of Kentucky (UK) Marquee Cancer Center, Has published an inviting review article entitled “Integration of Liquid Biopsy and Pharmacogenomics for the Precise Therapy of Resistant Lung Cancer”. The paper explores new options for diagnosing lung cancer.

Currently, tumor biopsy is the most widely used diagnostic tool for lung cancer. However, this paper talks about the huge potential of fluid biopsies obtained from blood samples for tumor biopsy transplantation for which patients have to undergo surgical procedures.

Together with Dr Mahadev Rao, the research paper was published jointly with a team from the University of Kentucky (UK) Marquee Cancer Center, led by Jill Koleser, Farm D., Director of the Center for Precision Medicine, Vice President of Molecular Tumors. Dr. Vivek Rangnekar, a professor at the UK Marquee Cancer Center and chair of the UK College of Pharmacy, is the co-director of the Marquee Cancer Center UK and the founding chair of the Global Cancer Consortium. The paper included a multidisciplinary team of oncologists, researchers, clinical pharmacists and basic scientists from MAHE. The study was also facilitated by the Global Cancer Consortium formed in 2020. The consortium aims to promote partnerships in cancer research, education and promotion activities worldwide.

Speaking on the collaborative research conducted with the help of Global Cancer Consortium, MAHE Vice-Chancellor Lieutenant General (Dr.) MD Venkatesh said, We are delighted with the contribution of Dr. Rao and his team in cancer research and wish them well in their future endeavors. “

Dr. Mahadev Rao, Head of the Department of Pharmaceutical Practice at Manipal College of Pharmaceutical Sciences, MAHE and Founder of the Global Cancer Consortium, said: Combining fluid biopsy in cancer care and research, selecting the right drug at specific doses, identifying population-level genomic landscapes, developing new drug molecules and developing cancers for cancer patients. Provides reduced and improved personalized cancer care “

Leave a Reply

Your email address will not be published.